{"id":3859,"date":"2024-12-18T09:18:20","date_gmt":"2024-12-18T09:18:20","guid":{"rendered":"https:\/\/delbertpharma.com\/?p=3859"},"modified":"2025-01-15T11:35:11","modified_gmt":"2025-01-15T11:35:11","slug":"delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb","status":"publish","type":"post","link":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/","title":{"rendered":"Delbert Pharma annonce l&rsquo;acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb"},"content":{"rendered":"<p><strong>Paris, le 13 d\u00e9cembre 2024 \u2013 Delbert Pharma, laboratoire pharmaceutique fran\u00e7ais engag\u00e9 dans la sauvegarde des m\u00e9dicaments essentiels, annonce l\u2019acquisition de la mol\u00e9cule aztreonam, pr\u00e9sentation injectable (Azactam\u00ae), aupr\u00e8s de Bristol-Myers Squibb<\/strong><\/p>\n<p>Cette acquisition marque une \u00e9tape majeure dans l\u2019histoire de Delbert Pharma qui \u00e9tend sa pr\u00e9sence internationale hors de l\u2019Europe dans le domaine de l\u2019infectiologie.<br \/>\nCette acquisition inclut les Autorisations de Mise sur le March\u00e9 (AMM), ainsi que le nom de marque des formes injectables de cet antibiotique (Azactam\u00ae 1g et Azactam\u00ae 2g) dans pr\u00e8s de 20 pays dans le monde o\u00f9 il est commercialis\u00e9.<br \/>\nLe transfert de ces Autorisations de Mise sur le March\u00e9 aura lieu de mani\u00e8re progressive dans les diff\u00e9rents pays sur l\u2019ann\u00e9e 2025 et Bristol Myers Squibb et ses partenaires locaux resteront les titulaires de ces AMM pendant cette p\u00e9riode de transition.<\/p>\n<p>Gr\u00e2ce \u00e0 son savoir-faire dans la relocalisation de la production, Delbert Pharma conduira \u00e9galement le transfert industriel pour la production d\u2019Azactam\u00ae et mettra tout en \u0153uvre pour garantir la continuit\u00e9 et la disponibilit\u00e9 du produit pour les patients dans le monde entier.<\/p>\n<p><em>\u00abCette acquisition symbolise une \u00e9tape importante dans notre strat\u00e9gie de croissance. En ajoutant Azactam\u00ae \u00e0 notre portefeuille d\u2019antibiotiques injectables, nous renfor\u00e7ons notre engagement pour un acc\u00e8s international aux traitements essentiels. C\u2019est une nouvelle \u00e9tape pour Delbert Pharma, qui illustre notre volont\u00e9 d\u2019\u00e9largir notre pr\u00e9sence au-del\u00e0 de l\u2019Europe et de continuer \u00e0 r\u00e9pondre aux besoins m\u00e9dicaux critiques dans le monde entier<\/em> \u00bb, d\u00e9clare Eric Fidelin, Directeur G\u00e9n\u00e9ral Ex\u00e9cutif de Delbert Pharma.<\/p>\n<p>Agir pour le maintien et le d\u00e9veloppement de m\u00e9dicaments dont l\u2019absence porte atteinte aux patients et \u00e0 l\u2019\u00e9quilibre des syst\u00e8mes de sant\u00e9 est notre raison d\u2019\u00eatre, et l\u2019acquisition d\u2019Azactam\u00ae vient renforcer l\u2019engagement de Delbert Pharma en tant que soci\u00e9t\u00e9 \u00e0 mission.<\/p>\n<p>Nous remercions Bristol Myers Squibb pour la confiance \u00e9tablie depuis de nombreuses ann\u00e9es entre nos deux laboratoires, Azactam \u00e9tant le quatri\u00e8me produit Bristol Myers Squibb acquis par Delbert Pharma en 10 ans.<\/p>\n<p><strong>\u00c0 propos de Delbert Pharma<\/strong><\/p>\n<p>Delbert Pharma est un laboratoire pharmaceutique fran\u00e7ais ind\u00e9pendant, fond\u00e9 en 2013, soci\u00e9t\u00e9 \u00e0 mission depuis 2023, d\u00e9di\u00e9 \u00e0 la sauvegarde des m\u00e9dicaments essentiels pour l\u2019\u00e9quilibre des syst\u00e8mes de sant\u00e9. Delbert Pharma propose une large gamme de traitements en infectiologie, en neurologie et en onco-h\u00e9matologie r\u00e9pondant aux besoins m\u00e9dicaux critiques en Europe et au-del\u00e0. L\u2019entreprise est fortement engag\u00e9e dans la lutte contre les p\u00e9nuries de m\u00e9dicaments et la r\u00e9industrialisation pharmaceutique.<\/p>\n<p><strong>\u00a0<\/strong><strong>\u00c0 propos d\u2019Azactam<\/strong><\/p>\n<p>Aztreonam (Azactam\u00ae) est un antibiotique injectable de la classe des monobactames, principalement utilis\u00e9 dans le traitement des infections s\u00e9v\u00e8res caus\u00e9es par des bact\u00e9ries Gram n\u00e9gatives, telles que les septic\u00e9mies, les infections des voies urinaires, de la peau et des parties molles, broncho-pulmonaires, intra-abdominales et gyn\u00e9co-obst\u00e9tricales.<\/p>\n<p>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Paris, le 13 d\u00e9cembre 2024 \u2013 Delbert Pharma, laboratoire pharmaceutique fran\u00e7ais engag\u00e9 dans la sauvegarde des m\u00e9dicaments essentiels, annonce l\u2019acquisition de la mol\u00e9cule aztreonam, pr\u00e9sentation injectable (Azactam\u00ae), aupr\u00e8s de Bristol-Myers Squibb Cette acquisition marque une \u00e9tape majeure dans l\u2019histoire de Delbert Pharma qui \u00e9tend sa pr\u00e9sence internationale hors de l\u2019Europe dans le domaine de l\u2019infectiologie. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-3859","post","type-post","status-publish","format-standard","hentry","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Delbert Pharma annonce l&#039;acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb - delbertpharma.com<\/title>\n<meta name=\"description\" content=\"delbertpharma.com laboratoires pharmaceutique fran\u00e7ais \u0153uvrant pour la sauvegarde de m\u00e9dicaments essentiels dans les domaines de l&#039;infectiologie, pneumologie, oncologie, h\u00e9matologie, le syst\u00e8me nerveux central\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Delbert Pharma annonce l&#039;acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb - delbertpharma.com\" \/>\n<meta property=\"og:description\" content=\"delbertpharma.com laboratoires pharmaceutique fran\u00e7ais \u0153uvrant pour la sauvegarde de m\u00e9dicaments essentiels dans les domaines de l&#039;infectiologie, pneumologie, oncologie, h\u00e9matologie, le syst\u00e8me nerveux central\" \/>\n<meta property=\"og:url\" content=\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/\" \/>\n<meta property=\"og:site_name\" content=\"delbertpharma.com\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-18T09:18:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-15T11:35:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/delbertpharma.com\/wp-content\/uploads\/2024\/06\/DelbertPharma-logo-carre_719x556.png\" \/>\n\t<meta property=\"og:image:width\" content=\"719\" \/>\n\t<meta property=\"og:image:height\" content=\"556\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/delbertpharma.com\/#\/schema\/person\/3f5e468946ddee01e5b24b14a918dc12\"},\"headline\":\"Delbert Pharma annonce l&rsquo;acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb\",\"datePublished\":\"2024-12-18T09:18:20+00:00\",\"dateModified\":\"2025-01-15T11:35:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/\"},\"wordCount\":506,\"publisher\":{\"@id\":\"https:\/\/delbertpharma.com\/#organization\"},\"articleSection\":[\"Unclassified\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/\",\"url\":\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/\",\"name\":\"Delbert Pharma annonce l'acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb - delbertpharma.com\",\"isPartOf\":{\"@id\":\"https:\/\/delbertpharma.com\/#website\"},\"datePublished\":\"2024-12-18T09:18:20+00:00\",\"dateModified\":\"2025-01-15T11:35:11+00:00\",\"description\":\"delbertpharma.com laboratoires pharmaceutique fran\u00e7ais \u0153uvrant pour la sauvegarde de m\u00e9dicaments essentiels dans les domaines de l'infectiologie, pneumologie, oncologie, h\u00e9matologie, le syst\u00e8me nerveux central\",\"breadcrumb\":{\"@id\":\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/delbertpharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Delbert Pharma annonce l&#8217;acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/delbertpharma.com\/#website\",\"url\":\"https:\/\/delbertpharma.com\/\",\"name\":\"Delbert pharma\",\"description\":\"sauvegarder les m\u00e9dicaments essentiels\",\"publisher\":{\"@id\":\"https:\/\/delbertpharma.com\/#organization\"},\"alternateName\":\"Laboratoires Delbert\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/delbertpharma.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/delbertpharma.com\/#organization\",\"name\":\"Delbert Pharma\",\"alternateName\":\"Delbert Pharma\",\"url\":\"https:\/\/delbertpharma.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/delbertpharma.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/delbertpharma.com\/wp-content\/uploads\/2024\/06\/DELBERT-PHARMA-LOGO-500px.png\",\"contentUrl\":\"https:\/\/delbertpharma.com\/wp-content\/uploads\/2024\/06\/DELBERT-PHARMA-LOGO-500px.png\",\"width\":500,\"height\":386,\"caption\":\"Delbert Pharma\"},\"image\":{\"@id\":\"https:\/\/delbertpharma.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/delbert-pharma\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/delbertpharma.com\/#\/schema\/person\/3f5e468946ddee01e5b24b14a918dc12\",\"name\":\"admin\",\"sameAs\":[\"https:\/\/delbertpharma.com\"],\"url\":\"https:\/\/delbertpharma.com\/fr\/author\/edv_0xxiv2po\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Delbert Pharma annonce l'acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb - delbertpharma.com","description":"delbertpharma.com laboratoires pharmaceutique fran\u00e7ais \u0153uvrant pour la sauvegarde de m\u00e9dicaments essentiels dans les domaines de l'infectiologie, pneumologie, oncologie, h\u00e9matologie, le syst\u00e8me nerveux central","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/","og_locale":"fr_FR","og_type":"article","og_title":"Delbert Pharma annonce l'acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb - delbertpharma.com","og_description":"delbertpharma.com laboratoires pharmaceutique fran\u00e7ais \u0153uvrant pour la sauvegarde de m\u00e9dicaments essentiels dans les domaines de l'infectiologie, pneumologie, oncologie, h\u00e9matologie, le syst\u00e8me nerveux central","og_url":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/","og_site_name":"delbertpharma.com","article_published_time":"2024-12-18T09:18:20+00:00","article_modified_time":"2025-01-15T11:35:11+00:00","og_image":[{"width":719,"height":556,"url":"https:\/\/delbertpharma.com\/wp-content\/uploads\/2024\/06\/DelbertPharma-logo-carre_719x556.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/#article","isPartOf":{"@id":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/"},"author":{"name":"admin","@id":"https:\/\/delbertpharma.com\/#\/schema\/person\/3f5e468946ddee01e5b24b14a918dc12"},"headline":"Delbert Pharma annonce l&rsquo;acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb","datePublished":"2024-12-18T09:18:20+00:00","dateModified":"2025-01-15T11:35:11+00:00","mainEntityOfPage":{"@id":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/"},"wordCount":506,"publisher":{"@id":"https:\/\/delbertpharma.com\/#organization"},"articleSection":["Unclassified"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/","url":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/","name":"Delbert Pharma annonce l'acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb - delbertpharma.com","isPartOf":{"@id":"https:\/\/delbertpharma.com\/#website"},"datePublished":"2024-12-18T09:18:20+00:00","dateModified":"2025-01-15T11:35:11+00:00","description":"delbertpharma.com laboratoires pharmaceutique fran\u00e7ais \u0153uvrant pour la sauvegarde de m\u00e9dicaments essentiels dans les domaines de l'infectiologie, pneumologie, oncologie, h\u00e9matologie, le syst\u00e8me nerveux central","breadcrumb":{"@id":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/delbertpharma.com\/fr\/delbert-pharma-announces-the-acquisition-of-azactam-aztreonam-from-bristol-myers-squibb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/delbertpharma.com\/"},{"@type":"ListItem","position":2,"name":"Delbert Pharma annonce l&#8217;acquisition de Azactam\u00ae (aztreonam) de Bristol Myers Squibb"}]},{"@type":"WebSite","@id":"https:\/\/delbertpharma.com\/#website","url":"https:\/\/delbertpharma.com\/","name":"Delbert pharma","description":"sauvegarder les m\u00e9dicaments essentiels","publisher":{"@id":"https:\/\/delbertpharma.com\/#organization"},"alternateName":"Laboratoires Delbert","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/delbertpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/delbertpharma.com\/#organization","name":"Delbert Pharma","alternateName":"Delbert Pharma","url":"https:\/\/delbertpharma.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/delbertpharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/delbertpharma.com\/wp-content\/uploads\/2024\/06\/DELBERT-PHARMA-LOGO-500px.png","contentUrl":"https:\/\/delbertpharma.com\/wp-content\/uploads\/2024\/06\/DELBERT-PHARMA-LOGO-500px.png","width":500,"height":386,"caption":"Delbert Pharma"},"image":{"@id":"https:\/\/delbertpharma.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/delbert-pharma\/"]},{"@type":"Person","@id":"https:\/\/delbertpharma.com\/#\/schema\/person\/3f5e468946ddee01e5b24b14a918dc12","name":"admin","sameAs":["https:\/\/delbertpharma.com"],"url":"https:\/\/delbertpharma.com\/fr\/author\/edv_0xxiv2po\/"}]}},"_links":{"self":[{"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/posts\/3859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3859"}],"version-history":[{"count":4,"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/posts\/3859\/revisions"}],"predecessor-version":[{"id":3899,"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/posts\/3859\/revisions\/3899"}],"wp:attachment":[{"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/delbertpharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}